Titan Company Ltd

Process status

• Dematerialisation/rematerialisation details for the period have been processed and furnished to exchanges.
• Dematerialised securities are listed on the stock exchanges where the earlier issued securities were listed.
• Physical certificates received for dematerialisation were mutilated and cancelled; depository as registered owner substituted within 15 days.

Titan Company Limited: Trading Window closed from 23 September 2026; to reopen 48 hours after the board meeting to consider unaudited financial results for the quarter ending 30 September 2026

PSU grant details

• 7,35,550 PSUs granted to 168 eligible employees of Titan and subsidiaries.
• Each PSU entitles one fully paid-up equity share of ₹1 on vesting and exercise.
• Max shares issuable under Grant I equal 7,35,550, representing 0.08% of paid-up capital.
• Scheme implements via Titan Employee Stock Option Trust; no fresh company shares issued.
• Vesting occurs on 15 May 2029, subject to performance parameters.
• Exercisable within two years from vesting; no EPS dilution as no fresh shares issued.
• Scheme 2026 complies with SEBI SBEB Regulations, 2021; relates to grant I.
• Grant is subject to prescribed performance parameters and grant terms in the Explanatory Statement.
• Trust will acquire shares via secondary acquisition after meeting earlier Scheme 2023 obligations.

Postal Ballot Purpose

• Purpose: Approve director appointments, Scheme 2026 PSUs, and ESOP Trust secondary acquisition.

Resolution 1: Appointment of Director

• Ordinary; appoint Dr. D Karthikeyan, IAS as Director — approved; assent 96.77%, dissent 3.23%.

Resolution 2: Appointment of Director

• Ordinary; appoint K Vivekanandan, IAS as Director — approved; assent 98.73%, dissent 1.27%.

Resolution 3: Scheme 2026 – Titan employees

• Special; approve Scheme 2026 for Titan Company Limited employees — approved; assent 97.71%, dissent 2.29%.

Resolution 4: Scheme 2026 – subsidiary employees

• Special; approve Scheme 2026 for subsidiary employees — approved; assent 97.94%, dissent 2.06%.

Resolution 5: ESOP Trust secondary acquisition

• Special; authorize secondary acquisition by Titan Employee Stock Option Trust — approved; assent 98.30%, dissent 1.70%.

Meeting Details

• 22-Sep-2026, 10:00 a.m. to 5:00 p.m.; One-on-One & Group Meetings; Physical; JPM Conference.
• 22-Sep-2026, 5:00 p.m. to 6:00 p.m.; One-on-One meeting; Physical; Organizer: RARE Enterprises.
• Key company participant: General Counsel & Company Secretary.
• Purpose: Analyst and institutional investor meetings for general investor interaction.

Instruments and Ratings

• Commercial Paper ₹15,000 crore; CARE A1+; rating reaffirmed; CP limit enhanced from ₹7,500 crore.
• Long-term/Short-term bank facilities ₹5,525 crore; CARE AAA; Stable outlook; CARE A1+ reaffirmed.
• Short-term bank facilities ₹11,490 crore; CARE A1+; reaffirmed.

Rating Agency & Date

• Agency: CARE Ratings Ltd; rating assigned on 10 September 2026.
• Issuer: Titan Company Limited.

Outlook & Status

• Outlook: Stable for the long-term rating.
• Status: Reaffirmation across all listed instruments.

Meeting Details

• Sept 9, 2026; Kotak Mahindra Asset Management; one-on-one; physical; 3:00 PM–4:00 PM.
• Sept 9, 2026; ICICI Prudential Life Insurance Co; one-on-one; physical; 4:00 PM–5:00 PM.
• Sept 9, 2026; SBI Mutual Fund; one-on-one; physical; 5:00 PM–6:00 PM.
• Sept 9, 2026; Nippon Life Asset Management; one-on-one; physical; 6:00 PM–7:00 PM.

Purpose

• Analysts / Institutional Investors Meeting for general investor interaction.